PHILADELPHIA: Exciting times are ahead for Malaysia when one of the top Asian biopharmaceutical giants Biocon Ltd begins operations in the country next year.
Malaysia Biotechnology Corp (Biotech Corp) biomedical section senior vice-president Jay Padasian said it had taken about two years to convince the company to set up its integrated insulin plant in Malaysia.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
